Anti-LAG3 / CD223 Reference Antibody (mavezelimab), Monoclonal

Produktübersicht

• Artikelname: Anti-LAG3 / CD223 Reference Antibody (mavezelimab), Monoclonal
• Artikelnummer: SYB-CHB217
• Hersteller Artikelnummer: CHB217
• Alternativnummer: SYB-CHB217-100UG, SYB-CHB217-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics

Produktbeschreibung

Anti-LAG3 / CD223 Reference Antibody (mavezelimab)(CHB217) is expressed from CHO. The heavy chain type is IgG4SP, and the light chain type is kappa. It has a predicted MW of 145.98 kDa.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1mg/ml
• UniProt: P18627
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: LAG3 / CD223